Research output per year
Research output per year
Personal profile
Side activities
- Chairman of the Board of Directors Synox Therapeutics Ltd
- Member of the Board of Directors Mestag Therapeutics Ltd
- Interim CEO Mestag Therapeutics Ltd
- Member of the Board of Directors the Forbion European Acquistion Corporation
- Venture Partner Forbion Capital Partners
- Member of the Supervisory Board Stichting Utrecht Science Park
- Treasurer Edward Jenner Stichting
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR x LGR5 bispecific antibody with efficacy in epithelial tumors
Herpers, B., Eppink, B., James, M. I., Cortina, C., Cañellas-Socias, A., Boj, S. F., Hernando-Momblona, X., Glodzik, D., Roovers, R. C., van de Wetering, M., Bartelink-Clements, C., Zondag-van der Zande, V., Mateos, J. G., Yan, K., Salinaro, L., Basmeleh, A., Fatrai, S., Maussang, D., Lammerts van Bueren, J. J. & Chicote, I. & 19 others, , Apr 2022, In: Nature Cancer. 3, 4, p. 418-436 19 p.Research output: Contribution to journal › Article › Academic › peer-review
2 Citations (Scopus) -
Erratum: Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade (Cancer Cell (2018) 33(5) (922–936.e10), (S1535610818301740), (10.1016/j.ccell.2018.04.003))
Geuijen, C. A. W., De Nardis, C., Maussang, D., Rovers, E., Gallenne, T., Hendriks, L. J. A., Visser, T., Nijhuis, R., Logtenberg, T., de Kruif, J., Gros, P. & Throsby, M., 9 Aug 2021, In: Cancer Cell. 39, 8, p. 1163-1164 2 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
-
MCLA-117, a CLEC12AxCD3 bispecific antibody targeting a leukaemic stem cell antigen, induces T cell-mediated AML blast lysis
van Loo, P. F., Hangalapura, B. N., Thordardottir, S., Gibbins, J. D., Veninga, H., Hendriks, L. J. A., Kramer, A., Roovers, R. C., Leenders, M., de Kruif, J., Doornbos, R. P., Sirulnik, A., Throsby, M., Logtenberg, T., Dolstra, H. & Bakker, A. B. H., 3 Jul 2019, In: Expert Opinion on Biological Therapy. 19, 7, p. 721-733 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)1 Downloads (Pure) -
Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade
Geuijen, C. A. W., De Nardis, C., Maussang, D., Rovers, E., Gallenne, T., Hendriks, L. J. A., Visser, T., Nijhuis, R., Logtenberg, T., de Kruif, J., Gros, P. & Throsby, M., 14 May 2018, In: Cancer Cell. 33, 5, p. 922-936.e10Research output: Contribution to journal › Article › Academic › peer-review
1 Citation (Scopus) -
Generation of stable cell clones expressing mixtures of human antibodies
De Kruif, J., Kramer, A., Nijhuis, R., Van Der Zande, V., Den Blanken, R., Clements, C., Visser, T., Keehnen, R., Den Hartog, M., Throsby, M. & Logtenberg, T., 1 Aug 2010, In: Biotechnology and Bioengineering. 106, 5, p. 741-750 10 p.Research output: Contribution to journal › Article › Academic › peer-review
27 Citations (Scopus)